The Bio Chemistry Section plays a key role in the quality evaluation of biological products through biochemical and analytical testing. It provides crucial data on vaccine stability, adjuvant composition, protein concentration, and pH balance, ensuring every batch meets the required standards before release.
The section also contributes to research and development by supporting new vaccine formulations and validating biochemical markers for diagnostic use.
The laboratory is equipped with modern analytical and biochemical testing infrastructure, including:
The section actively participates in R&D projects aimed at improving vaccine formulations and identifying new biochemical markers for disease diagnostics. Collaborative work with production and QA/QC units enhances product quality and innovation.
All testing protocols follow institutional SOPs and international quality norms. The section adheres to Good Laboratory Practices (GLP) and ensures data integrity, traceability, and reproducibility through meticulous documentation and calibration systems.
The Bio Chemistry Section is committed to scientific precision, analytical reliability, and continuous improvement — ensuring that every product released reflects the highest standards of safety, stability, and efficacy.